BL0020
BL0020-201
Phase 2 small_molecule active
Quick answer
BL0020 for Small Cell Carcinoma of Lung is a Phase 2 program (small_molecule) at Shanghai Best-Link Bioscience with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Best-Link Bioscience
- Indication
- Small Cell Carcinoma of Lung
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active